Date & Time

March 1 – 2, 2024
The scientific programm is scheduled to start on Friday at 13:00 and end on Saturday at 13:30.


Novotel Krakow Centrum
Krakow, Poland


Please contact us at for any questions related to the meeting.


Colorectal cancer is the third most common cancer in men and the second most common cancer in women worldwide. Many factors may be responsible for the development of this disease, including genetic and environmental factors.

The CECOG Colon Cancer Academy is an academic symposium, which is supervised by an independent scientific committee of international highly recognized experts in the field:

Christoph Zielinski (Vienna, Austria)
Fortunato Ciardiello (Naples, Italy)
Piotr Wysocki, Krakow (Poland)
Iga Rawicka (EuropaColon Polska)

The program of the meeting includes plenary sessions as well as sidetracks for physicians, oncology nurses and patient advocates.

The meeting is intended and has provided a platform for international multidisciplinary exchange. Moreover, and foremost, the CECOG Colon Cancer Academy is intended to present newest advances in the treatment of colon cancer. Participants of the CECOG Colon Cancer Academy will be exposed to an extremely stimulating and interactive environment (highly respected international scientists, medical oncologists, surgeons, pathologists, radiologists, radiotherapists and basic scientists), enabling the exchange of ideas, and fostering partnerships.

The CECOG Colon Cancer Academy will feature the latest research from leading experts and will help build collaborations to advance the prevention, detection, and treatment of colon cancer. The Academy will also shed light on future aspects of care and treatment.

The meeting will cover the following content:

  • Risk Prediction of colorectal cancer – incidence and surveillance
  • Treatment for unresectable metastatic CRC: Systemic therapy (cytotoxic chemotherapy, biologic therapy such as antibodies to cellular growth factors,
  • immunotherapy, and their combinations)
  • Microbiome
  • Clinical trials update: Clinical trials completed in the past five years have demonstrated that tailoring treatment to the molecular and pathologic features of the tumor improves overall survival
  • Genomic profiling – somatic variants
  • Novel insights into pre-malignant tumors
  • Liquid biopsy
  • Treatment resistance, side effects, quality of life

You can find the final programme here.

Registration & Accomodation Booking

The number of participants is limited to a maximum of 100 attendees.

No registration fees are charged for this meeting. One night accommodation at the meeting hotel and a refund of travel expenses up to a maximum amont of EUR 300.- will be covered by CECOG.

Registration is facilitated through an application process with the CECOG team. Our aim is to curate a diverse conference that encompasses a range of perspectives by including different specialities, geographic regions and levels of experience.

Once the application process is concluded, accepted participants will be able to book their accommodation through the CECOG website. Please note that all travel arrangements are the responsibility of the participants. We strongly advise waiting for a confirmation from CECOG before making any travel plans.


Financial Support

We kindly thank the following sponsor for their support of the 2nd CECOG Colon Cancer Academy